HuffPo: Making PrEP Possible for Women

Three-and-a-half years ago, the U.S. Food and Drug Administration approved the HIV treatment drug Truvada as pre-exposure prophylaxis or PrEP for HIV prevention. It was a landmark moment in the decades-long effort to halt HIV transmission. This pill, when taken daily by an HIV-negative person, reduces the likelihood of acquiring HIV by more than 90 percent.